Dietary and pharmacologic control of atherosclerosis regression in cynomolgus macaques (Macaca fascicularis).
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000473:pathology / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D002784:Cholesterol / Q000378:metabolism; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003094:Collagen / Q000032:analysis; D003331:Coronary Vessels / Q000473:pathology; D003918:Dextrothyroxine / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004549:Elastin / Q000032:analysis; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000378:metabolism; D008252:Macaca fascicularis; D011743:Pyrimidines / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002791:Cholesterol, Dietary; D008055:Lipids; D008077:Lipoproteins, LDL; D011743:Pyrimidines; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D004176:Dipyridamole; C006253:pirinixic acid; D003094:Collagen; D004549:Elastin; D002784:Cholesterol; D001241:Aspirin